SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Siemens Healthineers AG (SMMNY) trades at a trailing P/E of 23.0, forward P/E of 17.8. Trailing earnings yield is 4.34%, forward earnings yield 5.62%. PEG 0.22 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (75/100, Pass) — P/E is below market average (23.0); PEG ≤ 1.0 — Peter Lynch undervalued (0.22); earnings yield beats bond yields (4.34%).
- Forward P/E 17.8 (down from trailing 23.0) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.22 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 4.34% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 5.62% as earnings recover.
Overall SharesGrow Score: 63/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
75/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — SMMNY
Valuation Multiples
P/E (TTM)23.0
Forward P/E17.8
PEG Ratio0.22
Forward PEG0.60
P/B Ratio0.00
P/S Ratio2.12
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.90
Forward EPS (Est.)$1.17
Book Value / Share$0.00
Revenue / Share$9.79
FCF / Share$0.00
Yields & Fair Value
Earnings Yield4.34%
Forward Earnings Yield5.62%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.33 |
$13.55B |
$1.31B |
9.7% |
| 2017 |
$0.35 |
$13.8B |
$1.43B |
10.3% |
| 2018 |
$0.32 |
$13.43B |
$1.27B |
9.4% |
| 2019 |
$0.39 |
$14.52B |
$1.57B |
10.8% |
| 2020 |
$0.35 |
$14.46B |
$1.41B |
9.8% |
| 2021 |
$0.39 |
$18B |
$1.73B |
9.6% |
| 2022 |
$0.45 |
$21.71B |
$2.04B |
9.4% |
| 2023 |
$0.34 |
$21.68B |
$1.51B |
7% |
| 2024 |
$0.44 |
$22.36B |
$1.94B |
8.7% |
| 2025 |
$0.90 |
$22.03B |
$2.02B |
9.2% |
